Tamika Providence

Travel & Tourism

Global airline industry at a crossroads as it faces terminal decline, says GlobalData

The coronavirus has had a drastic impact on the airline industry forcing companies such as British Airways to cease operations at major airports with developments in the last few days placing the airline industry at a crossroads, says GlobalData, a leading data and analytics company. Nick Wyatt, Head of R&A and Travel & Tourism at GlobalData, comments: […]

Retail

New electrical purchases will add spark to time spent at home, says GlobalData

Consumers that are self isolating will boost the UK electricals market in H1 2020, with spend forecast to rise 3.4% versus last year, as shoppers purchase laptops, TVs and kitchen appliances to make the prolonged period at home more comfortable, says GlobalData, a leading data and analytics company. Zoe Mills, Analyst at GlobalData, comments: “The […]

Medical Devices

Colorectal cancer screening tests market to surpass $2bn by 2028, says GlobalData

National Colorectal Cancer (CRC) Awareness Month is an opportunity to raise awareness and prevent future cases of CRC. Currently, the global market value for in-vitro diagnostics (IVD) tests for CRC screening is estimated at $771.25m. This is expected to increase even more strongly than test volumes, reaching $2bn by 2028 at a compound annual growth rate (CAGR) of 10%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Colorectal Cancer Screening Tests – In Vitro […]

Retail

Online channel may not be the saviour clothing retailers hoped for, says GlobalData

Since the UK Government enforced stores to close for the foreseeable future, many non-food retailers hoped that customers would divert spend onto their online channels. However, last week, Next – the UK’s third largest clothing retailer – announced that it was prioritising the safety of its employees by closing its distribution centre. As a result, […]

Pharma

MD1003 Phase III trial failure for multiple sclerosis treatment not wholly unexpected

Following the news that MedDay Pharmaceutical’s MD1003 for the treatment of non-active progressive forms of multiple sclerosis (MS) failed in a Phase III clinical trial; Philippa Salter, Neurology and Ophthalmology Analyst at GlobalData, a leading data and analytics company, offers her view: “Despite MD1003 demonstrating efficacy at reversing disease progression in a small percentage of […]

Prev 1 2 3 4

Global airline industry at a crossroads as it faces terminal decline, says GlobalData

New electrical purchases will add spark to time spent at home, says GlobalData

Colorectal cancer screening tests market to surpass $2bn by 2028, says GlobalData

Online channel may not be the saviour clothing retailers hoped for, says GlobalData

MD1003 Phase III trial failure for multiple sclerosis treatment not wholly unexpected

Browse

Company information